{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:57:38Z","timestamp":1771678658070,"version":"3.50.1"},"reference-count":18,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2019,10,11]]},"abstract":"<jats:sec><jats:title>Background &amp;Aims:<\/jats:title><jats:p>Direct Antiretroviral Agents (DAAs), sofosbuvir-based therapies, have opened a new era in the treatment of chronic HCV infection. The aim of the study was to investigate the potential use of baseline and in serial serum, AFP levels as a predictor for response to DAAs in patients with Chronic Hepatitis C.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>This multicenter observational study was carried out on 1716 chronic hepatitis C virusinfected patients who received direct anti-viral drugs for 12 weeks. The primary end point was sustained virological response at 12 weeks after the end of treatment determined by quantitative PCR for HCV RNA. Serum AFP was quantitatively assessed at baseline then after 12week after stoppage of treatment (SVR12).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>SVR12 rate was 97.8%. Elevated serum AFP was significantly higher in non -SVR group p value (&lt;0.001). There was a significantly marked decrease in AFP after treatment in comparison to pretreatment values. The multivariate logistic regression analysis on the resulting significant variable from the univariate analysis revealed that only AFP was significantly related to the response to direct antiviral therapy in patients with chronic hepatitis C with p &lt;0.001, OR 1.10 (95% CI 1.07:1.12). Other sociodemographic (e.g. Age, gender, BMI, ..) or laboratory factors (Hb, ANC, WBCs, \u2026) did not show any significant association with the patients\u2019 response to treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Serum AFP levels were a predictor for response in patients with chronic HCV with the administration of direct antiviral drugs.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871530319666190204154830","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T07:53:55Z","timestamp":1549526035000},"page":"1005-1011","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients with Chronic Hepatitis C: Real-world Results from 1716 Patients in Egypt"],"prefix":"10.2174","volume":"19","author":[{"given":"Rehab","family":"Badawi","sequence":"first","affiliation":[{"name":"Tropical Medicine & Infectious Diseases, Tanta University Faculty of Medicine, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Alboraie","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Al-Azhar University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherief","family":"Abd-Elsalam","sequence":"additional","affiliation":[{"name":"Tropical Medicine & Infectious Diseases, Tanta University Faculty of Medicine, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Z.","family":"Abourahma","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University, Assiut, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidi K.","family":"Ramadan","sequence":"additional","affiliation":[{"name":"Department of Tropical Medicine and Gastroenterology, Faculty of Medicine, Assiut University, Assiut, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ossama A.","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ain Shams University, Faculty of Medicine, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed H.A.","family":"Fouad","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ain Shams University, Faculty of Medicine, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaimaa","family":"Soliman","sequence":"additional","affiliation":[{"name":"Department of Public health and Community medicine, Menofia University, Menofia, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina A.","family":"Mohareb","sequence":"additional","affiliation":[{"name":"Department of Clinical pathology, Faculty of Medicine, Assiut University, Assiut, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Haydara","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherein M.","family":"Alnabawy","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Faculty of Medicine, Tanta University, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El kassas","sequence":"additional","affiliation":[{"name":"Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00004836-200103000-00014","volume":"32","author":"Chu C.W.","year":"2001","unstructured":"Chu C.W.; Hwang S.J.; Luo J.C.; Lai C.R.; Tsay S.H.; Li C.P.; Wu J.C.; Chang F.Y.; Lee S.D.; Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C. J Clin Gastroenterol 2001,32(3),240-244","journal-title":"J Clin Gastroenterol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/0016-5085(90)90037-2","volume":"98","author":"Greenberg F.","year":"1990","unstructured":"Greenberg F.; Rose E.; Alpert E.; Hereditary persistence of alpha-fetoprotein. Gastroenterology 1990,98(4),1083-1085","journal-title":"Gastroenterology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1089-3261(05)70158-6","volume":"5","author":"Johnson P.J.","year":"2001","unstructured":"Johnson P.J.; The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clin Liver Dis 2001,5(1),145-159","journal-title":"Clin Liver Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0929-6646(09)60054-1","volume":"108","author":"Tai W.C.","year":"2009","unstructured":"Tai W.C.; Hu T.H.; Wang J.H.; Hung C.H.; Lu S.N.; Changchien C.S.; Lee C.M.; Clinical implications of alpha-fetoprotein in chronic hepatitis C. J Formos Med Assoc 2009,108(3),210-218","journal-title":"J Formos Med Assoc"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"Lavanchy D.","year":"2011","unstructured":"Lavanchy D.; Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011,17(2),107-115","journal-title":"Clin Microbiol Infect"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1365-2893.2009.01115.x","volume":"16","author":"Lehman E.M.","year":"2009","unstructured":"Lehman E.M.; Wilson M.L.; Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009,16(9),650-658","journal-title":"J Viral Hepat"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1871526517666170417143216","volume":"17","author":"Ahmed O.A.","year":"2017","unstructured":"Ahmed O.A.; Kaisar H.H.; Hawash N.; Samir H.; Shabana S.S.T.; Hassan A.; Fouad M.; Rizk F.; Abd-Elsalam S.; Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in treatment of a cohort of Egyptian patients with hepatitis C virus infection. Infect Disord Drug Targets 2017,17(2),95-100","journal-title":"Infect Disord Drug Targets"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00705-017-3573-0","volume":"163","author":"Abd-Elsalam S.","year":"2018","unstructured":"Abd-Elsalam S.; Sharaf-Eldin M.; Soliman S.; Elfert A.; Badawi R.; Ahmad Y.K.; Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice. Arch Virol 2018,163(1),51-56","journal-title":"Arch Virol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/IDR.S153060","volume":"11","author":"Ahmed O.A.","year":"2018","unstructured":"Ahmed O.A.; Kaisar H.H.; Badawi R.; Hawash N.; Samir H.; Shabana S.S.; Fouad M.H.A.; Rizk F.H.; Khodeir S.A.; Abd-Elsalam S.; Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. Infect Drug Resist 2018,11,295-298","journal-title":"Infect Drug Resist"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2147\/IDR.S160593","volume":"11","author":"Ahmed O.A.","year":"2018","unstructured":"Ahmed O.A.; Elsebaey M.A.; Fouad M.H.A.; Elashry H.; Elshafie A.I.; Elhadidy A.A.; Esheba N.E.; Elnaggar M.H.; Soliman S.; Abd-Elsalam S.; Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infection. Infect Drug Resist 2018,11(11),441-445","journal-title":"Infect Drug Resist"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.3184","volume":"19","author":"Thomas D.L.","year":"2013","unstructured":"Thomas D.L.; Global control of hepatitis C: where challenge meets opportunity. Nat Med 2013,19(7),850-858","journal-title":"Nat Med"},{"key":"ref=12","first-page":"47","volume":"9","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Nguyen D.; Hu K.Q.; Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies. N Am J Med Sci (Boston) 2016,9(2),47-54","journal-title":"N Am J Med Sci (Boston)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/13651820410024049","volume":"7","author":"Bialecki E.S.","year":"2005","unstructured":"Bialecki E.S.; Di Bisceglie A.M.; Diagnosis of hepatocellular carcinoma. HPB (Oxford) 2005,7(1),26-34","journal-title":"HPB (Oxford)"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajg.2013.08.005","volume":"14","author":"El Raziky M.","year":"2013","unstructured":"El Raziky M.; Attia D.; El akel, W.; Shaker, O.; Khatab, H.; Abdo, S.; Elsharkawy, A.; Esmat, G. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalization after treatment. Arab J Gastroenterol 2013,14,94-98","journal-title":"Arab J Gastroenterol"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002391","volume":"3","author":"Abdoul H.","year":"2008","unstructured":"Abdoul H.; Mallet V.; Pol S.; Fontanet A.; Serum alpha-fetoprotein predicts treatment outcome in chronic hepatitis C patients regardless of HCV genotype. PLoS One 2008,3(6)","journal-title":"PLoS One"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1478-3231.2008.01750.x","volume":"28","author":"Gad R.R.","year":"2008","unstructured":"Gad R.R.; Males S.; El Makhzangy H.; Shouman S.; Hasan A.; Attala M.; El Hoseiny M.; Zalata K.; Abdel-Hamid M.; Fontanet A.; Mohamed M.K.; Esmat G.; Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C. Liver Int 2008,28(8),1112-1119","journal-title":"Liver Int"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0256-4947.51810","volume":"29","author":"Abdo A.A.","year":"2009","unstructured":"Abdo A.A.; Sanai F.M.; Predictors of sustained virologic response in hepatitis C genotype 4: beyond the usual suspects. Ann Saudi Med 2009,29(1),1-3","journal-title":"Ann Saudi Med"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/135965350701200506","volume":"12","author":"Males S.","year":"2007","unstructured":"Males S.; Gad R.R.; Esmat G.; Abobakr H.; Anwar M.; Rekacewicz C.; El Hoseiny M.; Zalata K.; Abdel-Hamid M.; Bedossa P.; Pol S.; Mohamed M.K.; Fontanet A.; Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C. Antivir Ther (Lond) 2007,12(5),797-803","journal-title":"Antivir Ther (Lond)"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T14:15:41Z","timestamp":1662905741000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169630\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530319666190204154830","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}